MedTrace Logo

Probiotics in Hospitalized Patients Study

NCT01596153 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-11-18

No results posted yet for this study

Summary

The purpose of this study is to compare the effect of enhanced probiotic (EP, Live Rx) versus placebo (PL) on the incidence of Clostridium difficile associated diarrhea (CDAD) or antibiotic associated diarrhea (AAD) in hospitalized patients initiated on antibiotics.

Conditions

  • Antibiotic Associated Diarrhea
  • Clostridium Difficile Associated Diarrhea

Interventions

DIETARY_SUPPLEMENT

Go Live

Enhanced Probiotic, one packet bid until 7 days after discontinuation of antibiotic

Sponsors & Collaborators

  • South Shore Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01596153 on ClinicalTrials.gov